TRAVOPROSTIN

TRAVOPROSTIN is a preservative-free ophthalmic solution of travoprost (0.004% w/v) developed and marketed by Eyekare Kilitch. As a prostaglandin F2-alpha analogue, it functions as a selective agonist for the prostaglandin FP receptor. The drug is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension, particularly those who are intolerant of or insufficiently responsive to other medications. It works by increasing uveoscleral outflow to lower intraocular pressure. A key feature of TRAVOPROSTIN is its formulation in a specialized multi-dose container that eliminates the need for preservatives, making it an ideal option for patients with ocular surface sensitivity or chronic use requirements.

Brand names

TRAVOPROSTIN

Other names

Travoprost Preservative Free Eye Drops